Jayne Cottam Sells 1,017,587 Shares of Assura Plc (LON:AGR) Stock

Assura Plc (LON:AGR) insider Jayne Cottam sold 1,017,587 shares of the stock in a transaction on Tuesday, August 12th. The shares were sold at an average price of GBX 50 ($0.68), for a total value of £508,793.50 ($689,608.97).

Jayne Cottam also recently made the following trade(s):

• On Tuesday, August 12th, Jayne Cottam sold 902,389 shares of Assura stock. The stock was sold at an average price of GBX 50 ($0.68), for a total value of £451,194.50 ($611,540.39).
• On Tuesday, August 5th, Jayne Cottam purchased 663 shares of Assura stock. The stock was purchased at an average price of GBX 49 ($0.66) per share, for a total transaction of £324.87 ($440.32).
• On Tuesday, July 22nd, Jayne Cottam sold 94,230 shares of Assura stock. The stock was sold at an average price of GBX 50 ($0.68), for a total value of £47,115 ($63,858.77).
• On Wednesday, July 9th, Jayne Cottam purchased 607 shares of Assura stock. The stock was purchased at an average price of GBX 50 ($0.68) per share, for a total transaction of £303.50 ($411.36).

Assura Stock Performance

AGR stock opened at GBX 47.72 ($0.65) on Friday. The company has a market cap of £1.55 billion, a P/E ratio of -45.61, a price-to-earnings-growth ratio of 3.60 and a beta of 0.37. Assura Plc has a 1 year low of GBX 35.24 ($0.48) and a 1 year high of GBX 50.95 ($0.69). The company has a debt-to-equity ratio of 85.05, a current ratio of 0.89 and a quick ratio of 2.84. The stock’s fifty day moving average price is GBX 49.82 and its 200-day moving average price is GBX 47.04.

Assura (LON:AGR) last released its quarterly earnings results on Monday, July 21st. The real estate investment trust reported GBX 3.50 ($0.05) earnings per share (EPS) for the quarter. Assura had a negative return on equity of 1.92% and a negative net margin of 18.09%. On average, equities analysts forecast that Assura Plc will post 3.5830389 earnings per share for the current year.

About Assura

Assura plc is a specialist healthcare property investor and developer. We enable better health outcomes through our portfolio of more than 600 healthcare buildings across the UK and Ireland, from which over six million patients are served.

We BUILD for health, having developed over 100 new healthcare buildings in our history, and at the heart of our strategy sits The Bigger Picture; Healthy Environment (E), Healthy Communities (S), Healthy Business (G).

Assura plc achieved B Corp certification in July 2024 – the first FTSE 250 business to do so.